ABSTRACT
riencing excessive blood loss is required to optimize outcomes. Successful treatment of the hemorrhaging pregnant woman is dependent on early recognition of bleeding, treatment of the underlying cause of the hemorrhage, and simultaneous restoration of adequate circulating volume. Unrecognized, undertreated, or untreated hemorrhage may result in hypovolemic shock, damage to essential body organs, cellular death and hemolysis, multiple organ dysfunction syndrome, and maternal death.
The purpose of this article is to review the pathophysiology of hypovolemic shock, clinical manifestations of hypovolemia and discuss collaborative nursing care and fluid volume resuscitation for the woman experiencing obstetric hemorrhage.
Certainly most obstetric hemorrhages encountered in practice do not result in the need for massive volume replacement and are managed with first line interventions such as fundal massage and increased intravenous (IV) fluids. This article is meant to address the specific issues of advanced and uncontrolled hemorrhage resulting in the need for acute volume resuscitation.
PHYSIOLOGIC ADAPTATIONS
The profound hemodynamic and hematologic changes that occur during pregnancy are protective against blood loss associated with childbirth but may also alter the usual, observed clinical manifestations of hypovolemic shock. Maternal blood volume increases by 1000 to 2000 mL above nonpregnant values during pregnancy. 2 Plasma volume is increased as much as 10% by the seventh week of pregnancy with a plateau of 40% to 45% occurring at 32 weeks' gestation. Red blood cell mass lags behind plasma volume changes but increases by 30% later in pregnancy. 3 Hypervolemia is further increased with the number of fetuses. 2 This increase in blood volume results in an increase in maternal cardiac output of 40% to 50%. Peripheral resistance is decreased because of relaxation of smooth muscle related to hormonal changes. Changes in both coagulation factors and the fibrinolytic cascade results in a hypercoaguable state. 4 Thus the mother is prepared for significant blood loss of up to 1000 mL with the average blood loss at birth approximately 600 mL. 2 These protective physiologic adaptations result in the mother's ability to experience significant blood loss before tachycardia and hypotension, the cardinal signs of hypovolemic shock develop. In the pregnant woman, hypotension and tachycardia are late signs that manifest after blood loss greater than 15% of the circulating blood volume. 5 During pregnancy, postpartum women are at increased risk of hemorrhage. See Table 1 for a list of the most common causes of obstetric hemorrhage. Table 2 describes classification of maternal hemorrhage with accompanying signs and symptoms of hypovolemic shock.
HYPOVOLEMIC SHOCK
Hypovolemic shock occurs when circulating blood volume is decreased and results in inadequate or uneven tissue oxygenation. Loss of blood volume stimulates the release of epinephrine and norepinephrine, resulting in vasoconstriction of both peripheral and central blood vessels. Vasoconstriction in the capillary beds results in an autotransfusion to the central circulation, temporarily increasing circulating blood volume. The catecholamine response also increases heart rate, vascular tone, and myocardial contractility, which aid in compensating for decreased volume. There is also a redistribution of circulating blood volume, a shunting of blood away from the skin, gut, uterus, and kidneys and redirecting of blood to the heart, brain, and lungs. If circulating volume is not restored these compensatory mechanism will fail resulting in inadequate perfusion at the cellular level, tissue hypoxia, metabolic acidosis, end organ dysfunction, and ultimately maternal death. Secondary complications of hypovolemia include acute tubular necrosis and acute respiratory distress syndrome both of which may be a significant cause of maternal mortality.
Hemorrhage may also cause significant disruptions to uterine and placental blood flow. Decreased oxygen carrying capacity results in decreased oxygen delivery to the fetus. Thus the fetus is at significant risk for progressive physiologic compromise if circulating blood volume cannot be restored. Evidence suggestive of fetal compromise, such as fetal tachycardia, decreased fetal heart rate variability, late decelerations and fetal bradycardia may indicate the need for increased volume and require increased surveillance and treatment. The risk to the fetus is related to both the amount and duration of maternal hemorrhage.
Clinical signs and symptoms of hypovolemic shock Diagnosis of hypovolemic shock is usually made in the presence of hypotension, oliguria, acidosis, and cardiovascular collapse that occur in the later stages of the shock response. Careful assessment of both the type and amount of bleeding should be done whenever hemorrhage is suspected. Blood loss is typically underestimated by healthcare providers and it is imperative that continued bleeding is assessed. Noninvasive clinical assessments can be easily performed at the bedside and should be initiated whenever bleeding is suspected. Although heart rate is a later sign of hemorrhage and shock, the nurse must be alert for any upward trending of maternal heart rate before the development of overt tachycardia. It is crucial to remember that tachycardia is a late sign of hemorrhage. Hypotension is also a late development. Thus trends in maternal blood pressure should also be carefully evaluated particularly in the context of continued bleeding. Respiratory rate will increase in the event of hemorrhage as a physiologic response to increase the level of oxygen in the blood. Rapid shallow respirations represent air hunger and may lead to acidosis. Altered mental status as evidenced by anxiety, restlessness, confusion, and decreased level of consciousness suggest decreased cerebral perfusion and are considered ominous signs. Cool, clammy, pale skin is a result of peripheral vasoconstriction. Pulse oximetry may not accurately reflect tissue oxygen saturation if peripheral vasoconstriction is significant and blood flow to the digits is compromised. Therefore, blood gas analysis may be necessary to follow oxygenation status. Maternal report of thirst and the presence of dry mucous membranes reflect fluid depletion and dehydration. Decreased renal perfusion may result in oliguria or anuria. Careful assessment of urine output with an indwelling urinary catheter provides assessment data that reflects renal perfusion and therefore maternal intravascular volume status. Later in the clinical course more invasive assessment tools may be necessary. Invasive hemodynamic monitoring including arterial lines, central venous pressure monitoring, and pulmonary artery catheters may be utilized if additional information is necessary to guide fluid resuscitation efforts.
COMMUNICATION
As essential as the clinical assessments are, it is also crucial that assessment findings be communicated effectively to all members of the healthcare team. Too often, there is an underresponse to abnormal vital signs coupled with denial of the significance of the assessment findings. This may result in delay of treatment and increased risk of adverse outcomes. The Joint Commission's 2010 Sentinel Event Alert, Preventing Maternal Death, recommends that hospitals institute the following standards so that each hospital has a standardized process for identifying and responding to a change in patient's conditions. 6 These recommendations include (1) having a process for recognizing and responding as soon as a patient's condition appears to be worsening, (2) development of written criteria describing early warning signs of a change or deterioration in a patient's condition and when to seek further assistance, and (3) based on the early warning criteria, staff should seek further assistance when they have a concern about a patient's condition. These recommendations are intended to help ensure that when there is a change in condition everyone on the team knows and understands the appropriate responses. Keen observation coupled with appropriate communication of assessment is the key to prompt recognition of the compromised patient, identifying and treating the cause of the hemorrhage and restoring circulating blood volume. These actions when undertaken in a timely manner can help to prevent the development of the secondary complications such as hypothermia, coagulopathy, and acidosis.
MANAGEMENT OF HYPOVOLEMIC SHOCK
The goals of treatment are to restore the woman to normal hemodynamic and oxygenation parameters, in a timely manner and thus optimize survival. 7 To achieve these goals, rapid oxygenation and fluid replacement are essential. It is recommended that specific triggers for responding to changes in vital signs and clinical conditions be developed.
Oxygenation
The most frequent cause of death in patients with hypovolemic shock is inadequate oxygen exchange leading to multiple organ failure. 8 When excessive bleeding is first noted, oxygen should be administered at 10 to 12 L/min flow rate via a nonrebreather face mask. This increase in maternal oxygenation has 2 significant benefits. First, administration of oxygen may delay the onset of tissue hypoxia by increasing the oxygen available to the tissue. In addition, the increase in the partial pressure of oxygen in the maternal circulation will increase the amount of oxygen available to the fetus, which is very significant if the bleeding occurs while the patient is still pregnant. 9 If the mother is unable to maintain a patent airway, endotracheal intubation should be done to improve oxygen delivery.
Volume replacement
Treatment of acute hemorrhage and hypovolemic shock requires prompt and aggressive IV volume replacement. The goals of volume replacement are listed in Table 3 . Initially, 2 large bore (14-18 gauge) IV catheters should be placed to facilitate rapid volume expansion. Central venous access may be required if the hemorrhage is extensive or ongoing. The IV fluids of choice for volume replacement during acute hemorrhage are isotonic crystalloid solutions, 0.9% sodium chloride and lactated ringer's solution. These fluids, used to support immediate resuscitation and perfusion, have the advantage of being able to rapidly expand intravascular volume, replenish intracellular water and electrolyte content and are readily available at relatively low cost. A disadvantage to the use of crystalloid solutions is interstitial edema as these fluids move easily out of the intravascular space. In addition, when given in large amounts, dilution of plasma proteins occurs, which leads to a decrease in colloid osmotic pressure and dilution of packed red blood cells. Thus, volume resuscitation with crystalloid solution alone may not be adequate to restore homeostasis during a significant hemorrhage.
Colloid solutions, such as albumin, dextran and hydroxyethyl starch may be used during acute volume resuscitation, however they have not been associated with any improvements in survival or reduction in the risk of dying. 10, 11 In addition, they are more expensive and not as readily available as crystalloid solutions in emergency situations.
Blood component therapy
In the event of significant hemorrhage volume replacement with crystalloid solution alone will not be sufficient for resuscitation. Blood component therapy may also be necessary. Although there is no one universal hematocrit or hemoglobin level that either mandates or contraindicates blood transfusion, the decision to transfuse blood must be based on a full assessment of the hemodynamic stability of the woman, the amount of blood loss, the potential for concealed blood loss (such as under surgical drapes or into the abdominal cavity), and the normalization of vital signs. 12 The type and amount of component therapy will differ depending on the clinical presentation, preexisting conditions, comorbidities, and the woman's individual needs.
Packed red blood cells (PRBCs)
Packed red blood cells are administered to increase oxygen-carrying capacity and delivery of oxygen to the tissues. In published guidelines, the American Society of Anesthesiologists' Task Force on Blood Product Replacement states that packed red blood cells are rarely indicated with a hemoglobin level greater than 10g/dL and virtually always necessary when hemoglobin levels fall below 6 g/dL. 13 One unit of PRBCs will increase hemoglobin by 1 gram/dL and will increase hematocrit by levels by 3% to 4%. Hemoglobin, hematocrit, estimated blood loss, vital signs, and evidence of end organ dysfunction are important considerations when making decisions related to transfusion of PRBCs.
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Fresh frozen plasma (FFP)
Fresh frozen plasma (FFP) is prepared by separating plasma from whole blood and then freezing the plasma. It contains plasma proteins and all the clotting factors. It requires 30 minutes to thaw and may not be immediately available in an emergent situation. Women are given FFP when a coagulopathy exists that needs to be corrected. FFP administration may be considered when the prothrombin time exceeds 2 times normal or the activated partial thromboplastin time is greater than 1.5 times normal. 13 In women who are hemorrhaging, coagulopathies may occur as a direct result of blood loss or as a secondary complication. Disseminated intravascular coagulation may also be the result of a consumptive coagulopathy that occurs when the clotting cascade is activated during periods of acute bleeding. Fresh frozen plasma is not considered a volume expander and should not be used for this purpose. One unit of FFP will increase fibrinogen levels by 10 mg/dL and most clotting factors by 5% to 7%.
Platelets
Platelet transfusion may be considered if bleeding continues, there is evidence of microvascular bleeding or to correct a platelet count of less than 50 000 u/L. Platelets are prepared by either aphoresis from a single donor or by pooling from 4 to 6 random donor platelet concentrates. 15 Platelets do not require cross-matching but in the obstetric population every effort should be made to avoid transfusing Rh positive platelets to a Rh negative recipient because of the slight risk of sensitization to the D-antigen. If this occurs Rh immunoglobin should be given to the woman to prevent sensitization. 16 Each unit of aphoresis platelets will increase the platelet count by 25 000-30 000 u/L.
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Cryroprecipitate
Cryroprecipitate is obtained when FFP is thawed, and it offers a more concentrated form of fibrinogen replacement. Fresh frozen plasma contains fibrinogen, factor VIII, fibronectin, von Willebrand factor and factor XII. Cryroprecipitate is given when fibrinogen levels are less than 80 to 100 mg/dL. 12 Each 40 mL unit of cryroprecipitate will raise fibrinogen levels 10 mg/dL.
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Risks of Transfusion
Risks related to transfusion range from mild to life threatening. Common transfusion risks are listed in Table 4 . Consideration of institutional policy for proper identification is required before administration of blood products. Standardized procedures regarding verification of orders, verification of the product, and pretransfusion assessment parameters must always be followed. In emergency situations, these standardized procedures are particularly essential in minimizing the potential for error and maximizing safety. Patient identification errors have been noted to be the most common cause of administration of incompatible blood to patients. 14 Appropriate assessments and documentation, according to institutional guidelines, should be completed during blood administration. Assessments include temperature, heart rate, respiratory rate, and blood pressure and should be done before initiating the transfusion and at prescribed intervals during the infusion. Any changes from baseline should be noted, documented, and reported. In the event of a suspected transfusion reaction, the blood product should be stopped immediately, but IV line with sodium chloride should remain open. The primary care provider and the blood bank should be notified, and further interventions will be based on symptoms and assessment parameters.
Recombinant human coagulation factor VIIa
Recombinant human coagulation factor VIIa, which was initially licensed for use in the management of hemophilia, is being used during uncontrollable, life-threatening hemorrhages. Activated recombinant factor VIIa acts by binding with tissue factor to augment the intrinsic clotting pathway by activating factors IX and X. 19 The majority of the data to support its use in postpartum hemorrhage comes from case reports and case series only. 18 It has been recommended that before administering activated recombinant factor VIIa, hypovolemia, acidosis, and thrombocytopenia should be corrected. 20 In addition, the safety of recombinant factor VIIa has not been fully established and it may be associated with an increase risk of arterial thromboembolytic events. 21 Additional study in the obstetric population is needed before widespread acceptance of this treatment is established.
Massive transfusion protocols/trauma exsanguination protocols
Efforts to reduce both morbidity and mortality associated with massive blood loss and the accompanying triad of hypothermia, acidosis and coagulopathy have led to the development of predefined, protocol driven early transfusion of PRBSs, platelets, FFP and crystalloid solutions. 22 These massive transfusion protocols or trauma exsanguination protocols clearly define the patient population and criteria that must be met before they are instituted. These protocols are intended to rapidly replace circulating blood volume with carefully selected crystalloid solutions and blood products given in a specific sequence in the massively transfused trauma patient. Massive transfusion protocols and trauma exsanguination protocols should be closely monitored for appropriate use, staff should be educated prior to implementation, and quality improvement processes should be in place when they are utilized. 23 Use of these protocols in obstetric women has not been studied but they may gain acceptance in the future.
Complications of hemorrhage and volume resuscitation
Women requiring massive and aggressive volume resuscitation are at significant risk for complications once the immediate crisis has passed. These complications include hypothermia, coagulopathies, acidosis, and electrolyte imbalances.
Hypothermia
Hypothermia is a serious complication of volume resuscitation. When body temperatures fall below 36
• C, the coagulation cascade slows, inhibiting clot formation and decreasing platelet function. A hypothermic environment increases the affinity of hemoglobin for oxygen, so less oxygen is released at the tissue level resulting in decreased tissue perfusion. Hypothermia may disrupt conduction system in the heart, predisposing the woman to arrhythmias. Finally, hypothermia decreases metabolic activity, which can lead to impaired drug activity and metabolism. 24 There are several nursing interventions that can decrease or minimize these complications. All IV solutions and blood products should be warmed with administration. There are several rapid infusion systems that can deliver large volumes of fluids in normothermic conditions. When rapid infusion systems are utilized for administration, fewer fluids and blood products are required and there are fewer complications noted than with conventional methods. 25 Other interventions include keeping the woman covered when possible, increasing the ambient temperature in the room, removing all wet linens promptly, using warm blankets or heated air convection blankets, and keeping the patient's head covered.
14 The woman's body temperature should be monitored and any hypothermia identified rapidly addressed.
Coagulapathy
Disseminated intravascular coagulation is a common complication of hemorrhage, where by the normal process of clot formation and clot degradation are significantly impaired. In addition, coagulation factors may be diluted out during rapid instillation of large amounts of fluid. Clotting factors and platelets are lost during hemorrhage along with plasma volume, so there are less available for clot formation. Control and elimination of the source of the bleeding along with replacement of platelets and clotting factors are the treatment for this condition.
Acidosis
Acidosis is also a significant contributor to the morbidity and mortality associated with hemorrhage. During periods of hypovolemia and hypoperfusion, there is an increase in the production of lactic acid and a decrease in metabolism of lactate. This buildup of lactate in the blood and tissues will lead to a metabolic acidosis. In addition, when sodium chloride is infused in large amounts, metabolic hyperchloremic acidosis can occur if the kidneys are not able to secrete enough bicarbonate to maintain proper acid-base balance. Adequate oxygenation and restoration of circulating volume are essential to reduce this acidotic state.
Electrolyte imbalance
Electrolyte imbalances are also a common complication in women who are hemorrhaging and require massive volume replacement. Women who have received large amounts of stored red blood cells may be at risk for hyperkalemia. When blood is stored, the red blood cells breakdown potassium becomes an extracellular fluid. Normally the excess potassium is moved back into the intracellular fluid via active transport or removed in the kidneys and excreted in the urine. However, in a critically ill woman this may not occur particularly if there is any degree of renal impairment. 26 In a woman receiving multiple units of stored blood, electrocardiography should be initiated, and the woman should be monitored for cardiac arrhythmias. If ECG changes, such as peaked T waves, lengthened PR intervals or wide QRS complexes develop, treatment for hyperkalemia may be necessary.
Citrate, a preservative used in stored blood, binds with both calcium and magnesium, which may lead to both hypocalcemia and hypomagnesium. Manifestations of hypocalcemia and hypomagnesium include cardiac arrhythmias, muscle weakness, hypotension, irritability, tetany, and psychosis. Treatment is electrolyte replacement and it is vital that laboratory values are monitored.
Recommendations
There is a growing body of literature describing the role of patient safety initiatives and simulation training in optimizing outcomes following postpartum hemorrhage.
27−33 Safety initiatives may include activities such as peer-review of maternal deaths, use of evidence-based protocols to guide management of postpartum hemorrhage, creation of obstetric medical emergency response team, and development of drills and simulations training for all members of the healthcare team. 33 Protocols that identify roles and responsibilities during acute hemorrhage should be developed for each institution. These triggers and protocols can be used when educating and training staff in the expected response to the identified triggers to a change in condition. 4 Hemorrhage drills and simulationbased training may help teams to achieve a timely and coordinated response in the treatment of postpartum hemorrhage. The development of obstetrical medical emergency team may also help to improve responses to obstetric emergencies. At Magee-Women's Hospital, implementation of an obstetrical medical emergency team led to a fourfold increase in the recognition of obstetric emergencies, including postpartum hemorrhage. 32 Additional research will be necessary to determine the impact of safety initiatives on maternal outcomes.
Obstetric critical care
Invasive hemodynamic monitoring and mechanical ventilation may be indicated in the event of acute hemorrhage requiring massive fluid resuscitation. Disseminated intravascular coagulopathy, acute kidney injury, and lung injury can result from hemorrhage and protracted hypovolemia. These complications may require the more precise and direct invasive assessment parameters provided by a pulmonary artery catheter to manage volume status. Endotracheal intubation may be necessary to optimize oxygen delivery. The use of invasive monitoring technology requires specialized nursing care where competencies in these critical care advanced technologies are established, either in the labor and delivery setting or another intensive care unit. Regardless of the physical location, caring for the critically ill obstetric woman is complex. The hemodynamic changes that normally occur during pregnancy may pose interpretive challenges for the nonobstetric critical care nurse. Conversely, continuous monitoring of direct invasive lines and the treatment parameters for volume resuscitation may pose challenges for the non-ICU nurse. A multidisciplinary approach will allow for outcome optimization by allowing each member of the team to contribute his or her knowledge and skills in care of the critically ill obstetric woman.
SUMMARY
Maternal hemorrhage remains a significant cause of maternal mortality. Most of the women who experience hemorrhage are at low risk without any identifiable clinical risk factors. 34 Care of the woman who requires acute volume resuscitation is an emergent event presenting unique challenges for the obstetric team. Prompt recognition, early and aggressive use of appropriate volume resuscitation interventions is key to successful care. Clear communications with providers, using predefined triggers to identify changes in patient condition, drills and simulations that include all members of the healthcare team are critical strategies that can be utilized to improve outcomes. Goals of therapy include eliminating the source of hemorrhage, restoration of circulating blood volume return, and return to homeostasis.
